188 related articles for article (PubMed ID: 9014776)
1. Oxytocin increases thresholds of colonic visceral perception in patients with irritable bowel syndrome.
Louvel D; Delvaux M; Felez A; Fioramonti J; Bueno L; Lazorthes Y; Frexinos J
Gut; 1996 Nov; 39(5):741-7. PubMed ID: 9014776
[TBL] [Abstract][Full Text] [Related]
2. Octreotide increases thresholds of colonic visceral perception in IBS patients without modifying muscle tone.
Bradette M; Delvaux M; Staumont G; Fioramonti J; Bueno L; Frexinos J
Dig Dis Sci; 1994 Jun; 39(6):1171-8. PubMed ID: 8200249
[TBL] [Abstract][Full Text] [Related]
3. Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome.
Delvaux M; Louvel D; Mamet JP; Campos-Oriola R; Frexinos J
Aliment Pharmacol Ther; 1998 Sep; 12(9):849-55. PubMed ID: 9768527
[TBL] [Abstract][Full Text] [Related]
4. The kappa agonist fedotozine relieves hypersensitivity to colonic distention in patients with irritable bowel syndrome.
Delvaux M; Louvel D; Lagier E; Scherrer B; Abitbol JL; Frexinos J
Gastroenterology; 1999 Jan; 116(1):38-45. PubMed ID: 9869600
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of colonic sensory thresholds in IBS patients using a barostat. Definition of optimal conditions and comparison with healthy subjects.
Bradette M; Delvaux M; Staumont G; Fioramonti J; Bueno L; Frexinos J
Dig Dis Sci; 1994 Mar; 39(3):449-57. PubMed ID: 8131679
[TBL] [Abstract][Full Text] [Related]
6. Effect of asimadoline, a kappa opioid agonist, on pain induced by colonic distension in patients with irritable bowel syndrome.
Delvaux M; Beck A; Jacob J; Bouzamondo H; Weber FT; Frexinos J
Aliment Pharmacol Ther; 2004 Jul; 20(2):237-46. PubMed ID: 15233705
[TBL] [Abstract][Full Text] [Related]
7. Visceral perception in irritable bowel syndrome. Rectal and gastric responses to distension and serotonin type 3 antagonism.
Zighelboim J; Talley NJ; Phillips SF; Harmsen WS; Zinsmeister AR
Dig Dis Sci; 1995 Apr; 40(4):819-27. PubMed ID: 7720476
[TBL] [Abstract][Full Text] [Related]
8. Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome.
Sagami Y; Shimada Y; Tayama J; Nomura T; Satake M; Endo Y; Shoji T; Karahashi K; Hongo M; Fukudo S
Gut; 2004 Jul; 53(7):958-64. PubMed ID: 15194643
[TBL] [Abstract][Full Text] [Related]
9. Irritable bowel syndrome patients show altered sensitivity to exogenous opioids.
Lembo T; Naliboff BD; Matin K; Munakata J; Parker RA; Gracely RH; Mayer EA
Pain; 2000 Aug; 87(2):137-147. PubMed ID: 10924807
[TBL] [Abstract][Full Text] [Related]
10. Sensational developments in the irritable bowel.
Naliboff B; Mayer EA
Gut; 1996 Nov; 39(5):770-1. PubMed ID: 9014782
[No Abstract] [Full Text] [Related]
11. An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome.
Simrén M; Abrahamsson H; Björnsson ES
Gut; 2001 Jan; 48(1):20-7. PubMed ID: 11115818
[TBL] [Abstract][Full Text] [Related]
12. Effect of a 5HT3-antagonist (ondansetron) on rectal sensitivity and compliance in health and the irritable bowel syndrome.
Hammer J; Phillips SF; Talley NJ; Camilleri M
Aliment Pharmacol Ther; 1993 Oct; 7(5):543-51. PubMed ID: 8280823
[TBL] [Abstract][Full Text] [Related]
13. Intraesophageal acid perfusion sensitizes the esophagus to mechanical distension: a Barostat study.
Hu WH; Martin CJ; Talley NJ
Am J Gastroenterol; 2000 Sep; 95(9):2189-94. PubMed ID: 11007216
[TBL] [Abstract][Full Text] [Related]
14. Intrarectal injection of glycerol induces hypersensitivity to rectal distension in healthy subjects without modifying rectal compliance.
Bouin M; Delvaux M; Blanc C; Lagier E; Delisle MB; Fioramonti J; Buéno L; Frexinos J
Eur J Gastroenterol Hepatol; 2001 May; 13(5):573-80. PubMed ID: 11396539
[TBL] [Abstract][Full Text] [Related]
15. Establishment of model of visceral pain due to colorectal distension and its behavioral assessment in rats.
Yang JP; Yao M; Jiang XH; Wang LN
World J Gastroenterol; 2006 May; 12(17):2781-4. PubMed ID: 16718770
[TBL] [Abstract][Full Text] [Related]
16. Differences in somatic perception in female patients with irritable bowel syndrome with and without fibromyalgia.
Chang L; Mayer EA; Johnson T; FitzGerald LZ; Naliboff B
Pain; 2000 Feb; 84(2-3):297-307. PubMed ID: 10666535
[TBL] [Abstract][Full Text] [Related]
17. Which is the best distension protocol to study rectal sensitivity in the irritable bowel syndrome?
Rey E; Alvarez Sánchez A; Díaz-Rubio M
Rev Esp Enferm Dig; 2002 Apr; 94(4):211-20. PubMed ID: 12185932
[TBL] [Abstract][Full Text] [Related]
18. Subtypes of constipation predominant irritable bowel syndrome based on rectal perception.
Harraf F; Schmulson M; Saba L; Niazi N; Fass R; Munakata J; Diehl D; Mertz H; Naliboff B; Mayer EA
Gut; 1998 Sep; 43(3):388-94. PubMed ID: 9863485
[TBL] [Abstract][Full Text] [Related]
19. Distension technique influences the relationship between colonic and rectal hypersensitivity in irritable bowel syndrome.
Ng C; Malcolm A; Hansen R; Kellow JE
Neurogastroenterol Motil; 2006 Mar; 18(3):206-10. PubMed ID: 16487411
[TBL] [Abstract][Full Text] [Related]
20. Perception of gastric distension. Influence of mode of distension on perception thresholds and gastric compliance.
Holtmann G; Gschossmann J; Guerra G; Goebell H; Talley NJ
Dig Dis Sci; 1995 Dec; 40(12):2673-7. PubMed ID: 8536530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
